Nova Patents
IL230862D0

Combination treatment (eg.with abt-072 or abt-333) of daas for use in treating hcv

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

75 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims24

Priority claims
DocumentOfficeKindDate
201161550360United States of AmericaP
201161562176United States of AmericaP
201261587197United States of AmericaP
201261600468United States of AmericaP
201261619883United States of AmericaP
201261656253United States of AmericaP
201261711793United States of AmericaP
2012061085United States of AmericaW
61550360–––
61562176–––
61587197–––
61600468–––
61619883–––
61656253–––
61711793–––
PCTUS2012061085–––
US201161550360P–––
US201161562176P–––
US201261587197P–––
US201261600468P–––
US201261619883P–––
US201261656253P–––
US201261711793P–––
WO2012US61085–––

Members75

Family members, oldest first
DocumentOfficeKind
CA2811250A1CanadaA1
CA2893379A1CanadaA1
EP2583680A2European Patent Office (EPO)A2
US2013102526A1United States of AmericaA1
US2013102558A1United States of AmericaA1
WO2013059638A1World Intellectual Property Organization (WIPO)A1
AU2013201532A1AustraliaA1
UY34401AUruguayA
TW201321002ATaiwan Province of ChinaA
EP2583680A3European Patent Office (EPO)A3
US8492386B2United States of AmericaB2
SE1450020A1SwedenA1
US2014057835A1United States of AmericaA1
GB201400674D0United KingdomD0
GB2506085AUnited KingdomA
IL230862A0IsraelA0
IL230862D0This recordIsraelD0
US8685984B2United States of AmericaB2
US2014107016A1United States of AmericaA1
SE1450131A1SwedenA1
AR088408A1ArgentinaA1
DE112012002813T5GermanyT5
GB201408664D0United KingdomD0
MX2014004729AMexicoA
GB201411074D0United KingdomD0
US8809265B2United States of AmericaB2
DE202012012955U1GermanyU1
CN104023726AChinaA
GB2511699AUnited KingdomA
AT514002A2AustriaA2
DE202012012954U1GermanyU1
GB2511699A8United KingdomA8
AU2013201532B2AustraliaB2
SG2014011670ASingaporeA
US2014323395A1United States of AmericaA1
JP2014530874AJapanA
GB201418014D0United KingdomD0
EA201490836A1Eurasian Patent Organization (EAPO)A1
PT107924APortugalA
PT107925APortugalA
GB2515942AUnited KingdomA
DK2583680T1DenmarkT1
ES2527544T1SpainT1
ES2529144A2SpainA2
JP5677646B2JapanB2
ZA201406351BSouth AfricaB
ZA201406352BSouth AfricaB
DE202012013117U1GermanyU1
DE12189195T1GermanyT1
ES2529144R1SpainR1
DE112012003457T5GermanyT5
CH707030B1SwitzerlandB1
CN104436197AChinaA
US8993578B2United States of AmericaB2
JP2015071599AJapanA
DE112012006327A5GermanyA5
US2015196615A1United States of AmericaA1
HK1199817AHong Kong, ChinaA
HK1199817A1Hong Kong, ChinaA1
HK1200022AHong Kong, ChinaA
HK1200022A1Hong Kong, ChinaA1
CA2811250CCanadaC
ES2529144B1SpainB1
TW201600087ATaiwan Province of ChinaA
PH12014502847A1PhilippinesA1
GB201601076D0United KingdomD0
TWI532485BTaiwan Province of ChinaB
ES2572330A2SpainA2
ES2572355A2SpainA2
NZ625539ANew ZealandA
ES2572330R1SpainR1
ES2572355R1SpainR1
BR112014005617A2BrazilA2
ES2572330B1SpainB1
ES2572355B1SpainB1